BNET Industries

NABI

(NABI) is in the Transportation Industry

Market Cap:$246.6M
Last Fiscal Year Sales:$380.0M
  • Public
  • US
Dow Jones Description

Mfr. & Sales of Buses

President & CEO
Andras Racz
Number of Employees 1,855
Contact Information

Ujszasz U 45

Budapest

(36) 1 4017399

NAICS Code School and Employee Bus Transportation: 485410

News & Analysis

nabi - All News and Analysis

  • Vaccine for smokers draws closer as GSK agrees US biotech deal

    BNET - 2009-11-17

    Smokers may soon be able to break their habit with an injectable vaccine that prevents nicotine in tobacco entering the brain, where it creates a highly addictive sensation of pleasure. The NicVAX vaccine moved closer to the market yesterday after a deal between GlaxoSmithKline and the US biotech company Nabi...

    Tags: habit, Vaccine, Tobacco, NABI

  • GSK deal draws smokers' vaccine closer

    BNET - 2009-11-16

    Smokers may soon be able to break their habit with an injectable vaccine that prevents nicotine in tobacco entering the brain, where it creates a highly addictive sensation of pleasure. The NicVAX vaccine moved closer to the market on Monday after a deal between GlaxoSmithKline and the US biotech company...

    Tags: Vaccine, Tobacco, NABI

  • Abbas, Saudi king meet

    - 2008-10-28

    RIYADH AFP — Palestinian president Mahmoud Abbas briefed Saudi King Abdullah Tuesday on preparations for talks next month aimed at reconciling Abbas's Fatah party and the Islamist group Hamas, his spokesman said. "President Abbas informed the Saudi sovereign about efforts underway to launch an intra-Palestinian dialogue on the basis...

    Tags: Agence France-Presse, NABI

  • Nabi Biopharmaceuticals changing name, moving headquarters to

    - 2007-12-05

    Nabi Biopharmaceuticals, which develops products to treat bacterial infection and nicotine addiction, said it completed the sale of its biologics unit to Biotest AG for $185 million in cash. Nabi announced the sale of its biologics unit to the German biotechnology company in September. The deal includes Nabi's plasma protein...

    Tags: NABI, Nabi Biopharmaceuticals

  • Pharmaceutical, staffing and cruising deals

    - 2007-11-01

    Boca Raton-based Nabi Biopharmaceuticals will sell its Nabi Biologics strategic business unit to Biotest Pharmaceuticals Corp. of Germany for $185 million. The sale includes Nabi's only on-market drug, Nabi-HB for hepatitis B, as well as all of its Boca Raton operations. Nabi will move its headquarters to Rockville. Md. Biotest...

    Tags: NABI

  • Biotest to acquire Nabi Biologics

    - 2007-10-01

    Nabi Biopharmaceuticals US has entered into a definitive agreement with Biotest AG Germany to sell the Nabi Biologies strategic business unit SBU to Biotest Pharmaceuticals Corporation for $185 million. Biotest researches and manufactures pharmaceutical, biotherapeutic and diagnostic products and has more than 1200 employees worldwide.Biotest has agreed to acquire the...

    Tags: NABI

  • Florida firm will consolidate in Rockville

    - 2007-09-13

    It has been a turbulent year for Nabi Biopharmaceuticals Inc. of Boca Raton, Fla., and after management shakeups and shareholder outrage, it seems the storm has dropped the company in a new home: Rockville. The Montgomery County seat has long been the site of Nabi's research and development...

    Tags: NABI

  • ISE Gasoline Hybrid Drive Systems to Power NABI Buses for Los Angeles Metro

    - 2007-09-04

    ISE Corporation recently received an order for its ThunderVolt™ gasoline hybrid-electric drive systems to power six NABI North American Bus Industries buses in the Los Angeles, CA area. Funded by the Advanced Transit Vehicle Consortium ATVC, the hybrid buses will be operated by the Los Angeles County Metropolitan Transportation Authority...

    Tags: ISE Corp., NABI

  • 3 NEW TYPHOON NAMES SELECTED

    - 2007-07-23

    According to news.gov.hk: Three new names for tropical cyclones in the western North Pacific and South China Sea have been selected. Pakhar, Doksuri and Haikui will replace Matsa, Nabi and Longwang. The Typhoon Committee, under the joint auspices of the United Nations Economic & Social Commission for Asia & the...

    Tags: NABI

  • Determining dimensions of reality: a concept mapping of the reality TV landscape

    - 2007-06-01

    The increased presence of reality-based programming across the television landscape has generated not only millions of dedicated viewers but also waves of scholarly interest in recent years. Such interest comes from a range of perspectives, including empirical investigations based on contemporary media effects theories (e.g., Kooistra, Mahoney, & Westervelt, 1998;...

    Tags: NABI

Decision Makers

Name (plus bio) Position
Andras Racz President & CEO
Russell Richardson COO
Andras Bodor Director, Corp Affairs
Peter Horvath Director, Finance

Board of Directors

Name (plus bio) Position
Csaba Zoltan Board of Directors
David A. Thompson Board of Directors
John Horstmann Board of Directors
Mark Pejacsevich Board of Directors
Tamas Felsen Board of Directors

Organization Position Status
NABI President & CEO Current
NABI Board of Directors Current

Organization Position Status
NABI COO Current
NABI Board of Directors Current

Organization Position Status
NABI Director, Corp Affairs Current
NABI Director, Corp Affairs Former

Organization Position Status
NABI Director, Finance Current
NABI Director, Finance Former

Organization Position Status
NABI Board of Directors Current

Organization Position Status
Abbott Diagnostics President Current
Hycor Biomedical, Inc. Board of Directors Current
LifeCell Corporation Board of Directors Current
NABI Board of Directors Current
Third Wave Technologies, Inc. Board of Directors Current
Third Wave Technologies, Inc. Chairman & President Former
Abbott Laboratories Vice President Former
Abbott Laboratories Corporate Officer Former
St. Jude Medical, Inc. Board of Directors Former

Organization Position Status
NABI Board of Directors Current

Organization Position Status
NABI Board of Directors Current

Organization Position Status
NABI Board of Directors Current
advertisement
Click Here
     NABI $4.87 +0.08 (1.67% )
Average Volume 288,089
Shares Outstanding 50.76M
Market Cap 247.2M
Year High 5.3
Year Low 2.15
Earnings Per Share -0.40
P/E Ratio -12.17
Dividend N/A
Yield N/A
advertisement
Click Here